567 related articles for article (PubMed ID: 19255944)
21. Site-directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decreases its capacity to upregulate antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase1 gene.
Bloom D; Dhakshinamoorthy S; Jaiswal AK
Oncogene; 2002 Mar; 21(14):2191-200. PubMed ID: 11948402
[TBL] [Abstract][Full Text] [Related]
22. The interaction of C-Rel with C/EBPbeta enhances C/EBPbeta binding to the C-reactive protein gene promoter.
Cha-Molstad H; Young DP; Kushner I; Samols D
Mol Immunol; 2007 Apr; 44(11):2933-42. PubMed ID: 17335903
[TBL] [Abstract][Full Text] [Related]
23. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.
Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J
Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127
[TBL] [Abstract][Full Text] [Related]
24. Role of C/EBP homologous protein (CHOP-10) in the programmed activation of CCAAT/enhancer-binding protein-beta during adipogenesis.
Tang QQ; Lane MD
Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12446-50. PubMed ID: 11050169
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus X protein transactivates inducible nitric oxide synthase gene promoter through the proximal nuclear factor kappaB-binding site: evidence that cytoplasmic location of X protein is essential for gene transactivation.
Majano P; Lara-Pezzi E; López-Cabrera M; Apolinario A; Moreno-Otero R; García-Monzón C
Hepatology; 2001 Dec; 34(6):1218-24. PubMed ID: 11732012
[TBL] [Abstract][Full Text] [Related]
26. Nrf2-mediated induction of detoxifying enzymes by alantolactone present in Inula helenium.
Seo JY; Lim SS; Kim JR; Lim JS; Ha YR; Lee IA; Kim EJ; Park JH; Kim JS
Phytother Res; 2008 Nov; 22(11):1500-5. PubMed ID: 18702092
[TBL] [Abstract][Full Text] [Related]
27. Induction of cancer chemopreventive enzymes by coffee is mediated by transcription factor Nrf2. Evidence that the coffee-specific diterpenes cafestol and kahweol confer protection against acrolein.
Higgins LG; Cavin C; Itoh K; Yamamoto M; Hayes JD
Toxicol Appl Pharmacol; 2008 Feb; 226(3):328-37. PubMed ID: 18028974
[TBL] [Abstract][Full Text] [Related]
28. The role of CCAAT/enhancer-binding protein beta in the transcriptional regulation of COX-2 in human amnion.
Lee YS; Terzidou V; Lindstrom T; Johnson M; Bennett PR
Mol Hum Reprod; 2005 Dec; 11(12):853-8. PubMed ID: 16399783
[TBL] [Abstract][Full Text] [Related]
29. Differential regulation of human hepatic flavin containing monooxygenase 3 (FMO3) by CCAAT/enhancer-binding protein beta (C/EBPbeta) liver inhibitory and liver activating proteins.
Klick DE; Shadley JD; Hines RN
Biochem Pharmacol; 2008 Jul; 76(2):268-78. PubMed ID: 18555208
[TBL] [Abstract][Full Text] [Related]
30. Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation.
Bae EJ; Kim SG
Mol Pharmacol; 2005 Sep; 68(3):660-9. PubMed ID: 15961673
[TBL] [Abstract][Full Text] [Related]
31. Cyclic AMP response element-binding protein (CREB) and CAAT/enhancer-binding protein beta (C/EBPbeta) bind chimeric DNA sites with high affinity.
Flammer JR; Popova KN; Pflum MK
Biochemistry; 2006 Aug; 45(31):9615-23. PubMed ID: 16878996
[TBL] [Abstract][Full Text] [Related]
32. CCAAT/enhancer binding protein beta mediates the activation of the murine alpha1(I) collagen promoter by acetaldehyde.
Attard FA; Wang L; Potter JJ; Rennie-Tankersley L; Mezey E
Arch Biochem Biophys; 2000 Jun; 378(1):57-64. PubMed ID: 10871045
[TBL] [Abstract][Full Text] [Related]
33. Repression of hepatitis B virus X gene expression by hammerhead ribozymes.
Kim YK; Junn E; Park I; Lee Y; Kang C; Ahn JK
Biochem Biophys Res Commun; 1999 Apr; 257(3):759-65. PubMed ID: 10208856
[TBL] [Abstract][Full Text] [Related]
34. Role of hypoxia-inducible factor-alpha in hepatitis-B-virus X protein-mediated MDR1 activation.
Han HK; Han CY; Cheon EP; Lee J; Kang KW
Biochem Biophys Res Commun; 2007 Jun; 357(2):567-73. PubMed ID: 17433259
[TBL] [Abstract][Full Text] [Related]
35. 1alpha-Hydroxylase transactivation by gamma-interferon in murine macrophages requires enhanced C/EBPbeta expression and activation.
Esteban L; Vidal M; Dusso A
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):131-7. PubMed ID: 15225760
[TBL] [Abstract][Full Text] [Related]
36. Hepatitis B virus X protein regulates transactivation activity and protein stability of the cancer-amplified transcription coactivator ASC-2.
Kong HJ; Park MJ; Hong S; Yu HJ; Lee YC; Choi YH; Cheong J
Hepatology; 2003 Nov; 38(5):1258-66. PubMed ID: 14578865
[TBL] [Abstract][Full Text] [Related]
37. A transcriptional role for C/EBP beta in the neuronal response to axonal injury.
Nadeau S; Hein P; Fernandes KJ; Peterson AC; Miller FD
Mol Cell Neurosci; 2005 Aug; 29(4):525-35. PubMed ID: 15936952
[TBL] [Abstract][Full Text] [Related]
38. All-trans retinoic acid-induced expression of bactericidal/permeability-increasing protein (BPI) in human myeloid cells correlates to binding of C/EBPbeta and C/EBPepsilon to the BPI promoter.
Lennartsson A; Vidovic K; Pass MB; Cowland JB; Gullberg U
J Leukoc Biol; 2006 Jul; 80(1):196-203. PubMed ID: 16684888
[TBL] [Abstract][Full Text] [Related]
39. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.
Shin CS; Jeon MJ; Yang JY; Her SJ; Kim D; Kim SW; Kim SY
J Mol Endocrinol; 2006 Jun; 36(3):531-46. PubMed ID: 16720721
[TBL] [Abstract][Full Text] [Related]
40. A critical role for C/EBPbeta binding to the AABS promoter response element in the human iNOS gene.
Guo Z; Shao L; Feng X; Reid K; Marderstein E; Nakao A; Geller DA
FASEB J; 2003 Sep; 17(12):1718-20. PubMed ID: 12958187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]